Oddo BHF Asset Management GmbH
Location
Nordrhein-Westfalen
Founded
1969-02-28
Website
Risk Signals
1708 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Security Brokers, Dealers, and Flotation Companies, Offices of Holding Companies, Not Elsewhere Classified, Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Oddo BHF Asset Management GmbH
Live alerts from global media, monitored by Business Radar
2024-11-21 (agefi.fr)
Oddo BHF launches its first evergreen fund aimed at individuals
This FCPR will only be accessible for life insurance and retirement savings. It will invest in the secondary private equity market in Europe, North America, Asia and the rest of the world.
Read more
2024-11-20 (boursier.com)
ODDO BHF launches its first evergreen fund, FCPR ODDO BHF Global Private Equity
This solution, accessible only for life insurance and retirement savings, allows you to invest in unlisted assets, with no limited lifespan.
Read more
2023-09-19 (allnews.ch)
ODDO BHF launches its first Investment Grade bond fund
Invested in the green, social and sustainable bond market, the fund aims to make a positive contribution to climate and environmental protection and social development.
Read more
2023-02-13 (lesechos.fr)
ODDO BHF launches a fund of funds in venture capital
This new vehicle is targeting a size of €200 million with investments in primary and secondary.
Read more
2023-01-10 (boersennews.de)
01/10/2023 - ANALYSIS FLASH: Oddo BHF launches Evotec with 'Outperform' - target 23 euros
FRANKFURT (dpa-AFX Broker) - The investment bank Oddo BHF has included Evotec in its rating with outperform and a target price of EUR 23. The currently low valuation ignores the drug researcher's strong, data-based technology platforms, wrote analyst Stephan Wulf in a...
Read more